Literature DB >> 5634742

Propranolol and isosorbide dinitrate synergism in angina pectoris.

H I Russek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5634742     DOI: 10.1016/0002-9149(68)90012-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  A review of beta-blockers and their use in general practice.

Authors:  J C Davies
Journal:  J R Coll Gen Pract       Date:  1976-03

Review 2.  Avoiding nitrate tolerance.

Authors:  J C Cowan
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

3.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

4.  Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris.

Authors:  J H Svendsen; O Amtorp
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Beta-adrenergic receptor blocking drugs in angina pectoris.

Authors:  B N Prichard
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Coronary and myocardial metabolic effects of combined glyceryl trinitrate and propranolol administration. Observations in patients with and without coronary disease.

Authors:  S J Schang; C J Pepine
Journal:  Br Heart J       Date:  1978-11

7.  New trends in the treatment of angina pectoris.

Authors:  D T Mason; J F Spann; R Zelis
Journal:  Calif Med       Date:  1969-09

8.  Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment.

Authors:  G Jensen; F Trautner; S Rasmussen; B Hesse
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Additive antianginal effect of verapamil in patients receiving propranolol.

Authors:  M Bassan; D Weiler-Ravell; O Shalev
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

10.  Molsidomine prevents post-ischaemic ventricular fibrillation in dogs.

Authors:  J P Cano; J C Guillen; R Jouve; F Langlet; P E Puddu; P H Rolland; A Serradimigni
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.